Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.73% | 193.48 | 1.2% | $597.74m | |
| GILD | Gilead Sciences, Inc. | -0.02% | 68.00 | 0.9% | $503.14m | |
| CELG | Celgene Corporation | -0.19% | 69.27 | 1.2% | $492.42m | |
| BIIB | Biogen Inc. | -0.89% | 316.37 | 1.3% | $463.44m | |
| ILMN | Illumina, Inc. | -0.53% | 300.00 | 3.5% | $379.69m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.00% | 339.00 | 2.6% | $298.68m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -2.45% | 161.07 | 1.9% | $260.54m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -3.00% | 115.06 | 2.0% | $199.08m | |
| A | Agilent Technologies, Inc. | -3.72% | 62.57 | 1.5% | $185.86m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.25% | 116.36 | 15.4% | $146.77m | |
| LGND | Ligand Pharmaceuticals Incorporated | -3.83% | 148.54 | 23.3% | $139.57m | |
| EXAS | Exact Sciences Corporation | 0.00% | 67.28 | 25.3% | $137.02m | |
| NKTR | Nektar Therapeutics | -2.11% | 37.21 | 5.6% | $119.67m | |
| INCY | Incyte Corporation | -3.40% | 64.25 | 2.5% | $115.74m | |
| TSRO | TESARO, Inc. | -0.41% | 36.68 | 14.4% | $108.95m |
Company Profile
Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the following segments: Biotechnology, Protein Platforms, Diagnostics, and Corporate. The Biotechnology segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and related reagents, as well as in situ hybridization, media and other cell culture products and reagents to the biotechnology research community. The Protein Platforms segment develops, manufactures, and sells tools to simplify protein analysis. The Diagnostics segment includes blood chemistry and blood gas quality controls, hematology instrument controls, diagnostic immunoassays, and other bulk and custom reagents for the in vitro diagnostic market worldwide. The company was founded on 1976 and is headquartered in Minneapolis, MN.